Orion Corporation

Orion Corporation (Finnish: Orion Oyj),[2][3] founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.

Orion Corporation
Native name
Orion Oyj
Julkinen osakeyhtiö
Traded asNasdaq Helsinki: ORNAV,ORNBV
ISINFI0009800346 
IndustryPharmaceutical industry
Founded1917 (1917)
HeadquartersEspoo, Finland
Key people
Timo Lappalainen (President and CEO), Hannu Syrjänen (Chairman)
ProductsPharmaceuticals, active pharmaceutical ingredients and diagnostic tests
Revenue €1.074 billion (2016)
€315 million (2016)
€249 million (2016)
Total assets €1.063 billion (2016)
Total equity €641 million (2016)
Number of employees
 3,446 (2016)
Websitewww.orion.fi/en
Footnotes / references
[1]

Orion's class A and B shares are listed on the Helsinki Stock Exchange.

Products
This list is incomplete; you can help by expanding it.
  • Anti-diabetic drugs
  • Cardiovascular drugs
  • Inotropic drugs
  • Hypolipidemic agents
gollark: **RESISTANCE IS FUTILE**
gollark: **YOU WILL BE PAGINATED**
gollark: ***P A G I N A T I O N***
gollark: __pagination__
gollark: ***pagination***

References
  1. https://www.orion.fi/globalassets/documents/orion-group/investors/annual-reports/orion-financial-statement-documents-2016.pdf
  2. "Orion Oyj". Business Information System. Finnish Patent and Registration Office and Finnish Tax Administration. Retrieved 22 October 2019.
  3. "Yhtiöjärjestys" [Corporate by-laws] (in Finnish). Espoo: Orion Oyj. 22 March 2017. Retrieved 22 October 2019.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.